People: MRI Interventions Inc (MRIC.OB)
MRIC.OB on OTC BB
1.20USD
23 May 2013
1.20USD
23 May 2013
Price Change (% chg)
$0.05 (+4.35%)
$0.05 (+4.35%)
Prev Close
$1.15
$1.15
Open
$1.15
$1.15
Day's High
$1.20
$1.20
Day's Low
$1.15
$1.15
Volume
129,150
129,150
Avg. Vol
115,925
115,925
52-wk High
$5.00
$5.00
52-wk Low
$0.75
$0.75
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Kimble Jenkins |
49 | 2004 | Chairman of the Board, President, Chief Executive Officer |
David Carlson |
48 | 2010 | Chief Financial Officer |
Peter Piferi |
52 | 2006 | Chief Operating Officer |
Robert Korn |
47 | 2012 | Vice President - Global Sales and Marketing |
Oscar Thomas |
41 | Vice President - Business Affairs, Secretary | |
Carol Barbre |
50 | 2008 | Vice President - Product Management |
Philip Pizzo |
2013 | Director | |
Michael Ryan |
34 | 2011 | Director |
Paul Bottomley |
58 | 1998 | Independent Director |
Charles Koob |
68 | 2008 | Independent Director |
James Malernee |
65 | 2010 | Independent Director |
Michael Pietrangelo |
70 | 2010 | Independent Director |
Andrew Rooke |
56 | 2011 | Independent Director |
John Spencer |
72 | 2010 | Independent Director |
Biographies
| Name | Description |
|---|---|
Kimble Jenkins |
Mr. Kimble L. Jenkins is Chairman of the Board, President, Chief Executive Officer of MRI Interventions Inc. Mr. Jenkins has served as President since January 2003, and he has also served as Chief Executive Officer since September 2004. Mr. Jenkins served in those offices on a part-time basis until May 2008, at which time Mr. Jenkins began serving as President and Chief Executive Officer on a full-time basis. Prior to May 2008, Mr. Jenkins was also a Managing Director with the investment bank Morgan Keegan & Company, Inc., where he founded that firm’s Private Equity Group in 1998. Mr. Jenkins has over 20 years of experience building and working with growth stage companies. Mr. Jenkins holds a Bachelor of Arts from Brown University and a Juris Doctorate from Georgetown University Law Center. |
David Carlson |
Mr. David W. Carlson is Chief Financial Officer of MRI Interventions Inc. Mr. Carlson joined the Company in February 2010 as Vice President, Finance and was promoted to Chief Financial Officer in April 2010. Mr. Carlson has 18 years of experience in financial leadership roles in the medical device industry. From 1999 to 2009, he served in various financial management positions as a Vice President of Finance and Senior Finance Director at Medtronic, Inc. He was serving as the Corporate Controller of Sofamor Danek, Inc., a then publicly traded medical device company, when it was acquired by Medtronic, Inc. in 1999. Mr. Carlson is a certified public accountant, and was formerly an auditor for PricewaterhouseCoopers LLP. |
Peter Piferi |
Mr. Peter G. Piferi is Chief Operating Officer of MRI Interventions Inc. Mr. Piferi has over 20 years of experience in the areas of product development, operations, engineering and production in the medical device industry. From March 2003 to December 2006, Mr. Piferi served as Vice President, Endovascular Technologies for Edwards Lifesciences Corporation. In addition, Mr. Piferi has served as Vice President at Kriton Medical Inc. and Orbus Medical Technologies, Inc. and as Director of Advanced Engineering at Cordis Corporation. |
Robert Korn |
Mr. Robert C. Korn is Vice President - Global Sales and Marketing of MRI Interventions Inc. Mr. Korn has over 20 years of experience in the health care industry focused in the medical device sales and marketing business. During his career, Mr. Korn gained experience in developing and implementing sales and marketing strategies for both Fortune 500 and startup companies. He has also worked on business development and acquisition opportunities in the medical device sector. From May 2005 to November 2012, Mr. Korn served as a Regional Sales Director with Medtronic Surgical Technologies, the neurosurgery, ear, nose and throat (ENT) and advanced energy business of Medtronic, Inc., a publicly traded medical device company. From April 2004 to April 2005, he served as Senior Vice President for Vassol, Inc., a private company, where he was responsible for the company’s sales and marketing functions. Prior to Vassol, Mr. Korn held various sales leadership positions with Codman, a Johnson & Johnson company, and he also held multiple sales and marketing positions with the Bayer Corporation’s Diagnostics Division. |
Oscar Thomas |
Mr. Oscar L. Thomas is Vice President - Business Affairs, Secretary of MRI Interventions Inc. From January 2003 to April 2008, Mr. Thomas was a partner in the Corporate and Securities Practice Group of the law firm Bass, Berry & Sims PLC. Mr. Thomas spent 12 years in private practice representing clients in a broad range of transactions, including licensing transactions, development collaborations, joint ventures, merger and acquisition transactions, and debt and equity financings. |
Carol Barbre |
Ms. Carol J. Barbre is Vice President - Product Management of MRI Interventions Inc. Ms. Barbre has 20 years of experience in the medical device industry in the areas of marketing and business development, with a focus on new medical therapies. From May 2007 to May 2008, Ms. Barbre served as Senior Director of Marketing for Edwards Lifesciences Corporation, a publicly traded medical device company. From 2002 to May 2007, Ms. Barbre served as Global Marketing Director for Bolton Medical, Inc., a privately held medical device company. |
Philip Pizzo |
Dr. Philip A. Pizzo, M.D., has been appointed as Director of MRI Interventions, Inc., effective April 12, 2013. Dr. Pizzo served as Dean of the Stanford School of Medicine from April 2001 to December 1, 2012, where he was also the Carl and Elizabeth Naumann Professor of Pediatrics and of Microbiology and Immunology. Dr. Pizzo has devoted much of his distinguished medical career to the diagnosis, management, prevention and treatment of childhood cancers and the infectious complications that occur in children whose immune systems are compromised by cancer and AIDS. Before joining Stanford, Dr. Pizzo was the physician-in-chief of Children’s Hospital in Boston and chair of the Department of Pediatrics at Harvard Medical School from 1996 to 2001. He is the author of more than 500 scientific articles and 16 books and monographs. The Company believes Dr. Pizzo offers a deep understanding of medical sciences and innovation, as well as physicians and other health care providers who are central to the use and development of the Company’s products. Dr. Pizzo received his M.D. degree from the University of Rochester in 1970. |
Michael Ryan |
Mr. Michael J. Ryan is Director of MRI Interventions Inc. Mr. Ryan is Director of Corporate Business Development at Boston Scientific, where he leads business development activities in the field of neuromodulation. Prior to joining Boston Scientific in 2005, Mr. Ryan was a Senior Consultant at Decision Resources, providing management consulting services to the pharmaceutical and biotech industries. |
Paul Bottomley |
Dr. Paul A. Bottomley is Independent Director of MRI Interventions Inc. Dr. Bottomley joined Johns Hopkins in 1994. Since 1997, Dr. Bottomley has served as the Director of the Division of MR Research in the Department of Radiology at Johns Hopkins. Previously, Dr. Bottomley worked at General Electric Company’s Research and Development Center from 1980 to 1994 where he played a key role in the development of their MRI clinical product and was awarded the Center’s highest honor, its Coolidge Medal and Fellowship, for these developments in 1990. He was awarded the Society of Magnetic Resonance in Medicine’s Gold Medal for his contributions to MRI in 1989. He holds over 30 U.S. patents and has written more than 150 scientific journal publications. |
Charles Koob |
Mr. Charles E. Koob is Independent Director of MRI Interventions Inc. From 1970 to 2008, Mr. Koob practiced competition, trade regulation and antitrust law at the law firm of Simpson Thacher & Bartlett and served as the co-head of the firm’s litigation department for a portion of his tenure. For much of his career, Mr. Koob served as a strategic advisor for the boards of directors of many public companies. Mr. Koob presently serves on the board of directors of MiMedx Group, Inc., a publicly traded biomedical products company, DemeRx, Inc., a privately held biotechnology company, and Stanford Hospital & Clinics. |
James Malernee |
Dr. James K. Malernee, Jr., is Independent Director of MRI Interventions Inc. Dr. Malernee is a cofounder of Cornerstone Research, Inc., a consulting firm specializing in analytical support to attorneys in all phases of commercial litigation and regulatory proceedings, and he currently serves as Chairman of that firm. Over the last twenty years with Cornerstone Research, he has directed research on complex business issues related to a wide variety of cases. Dr. Malernee has served as a board member and consultant to corporations, and he has taught finance at the University of Texas at Austin and business strategy at the Stanford Graduate School of Business. Dr. Malernee is also a consultant to RealPage, Inc. a publicly traded provider of property management solutions. |
Michael Pietrangelo |
Mr. Michael A. Pietrangelo is Independent Director of MRI Interventions Inc. From 1972 through 1989, Mr. Pietrangelo was employed by Schering-Plough Corporation in various capacities including President of the Personal Care Products Group. From 1989 to 1990, he served as President and Chief Operating Officer of Western Publishing Company. From 1990 to 1994, Mr. Pietrangelo was the President and Chief Executive Officer of CLEO, Inc., a subsidiary of Gibson Greetings, Inc. From 1994 until 1998, he served as President of Johnson Products Company, a subsidiary of IVAX Corporation. Since 1998, Mr. Pietrangelo has practiced law at Pietrangelo Cook PLC. Mr. Pietrangelo is also a director of Medicis Pharmaceutical Corporation, a publicly traded pharmaceutical company, serving on the executive committee (Chair), compliance committee (Chair), and nominating and governance committee. Mr. Pietrangelo also serves on the board of directors of the American Parkinson Disease Association, a not-for-profit organization focused on serving the Parkinson’s community, and Universal Insurance Holdings, Inc., a publicly traded insurance holding company. Mr. Pietrangelo currently serves as the managing partner of Theraplex Company LLC, a privately held company. |
Andrew Rooke |
Mr. Andrew K. Rooke is Independent Director of MRI Interventions Inc. Mr. Rooke owns and manages a private trust company, which specializes in the investment management of publicly held securities and the oversight of a multitude of trust investments. Over the years, he has acquired, managed and sold a number of private companies as well as commercial real estate properties. Mr. Rooke was also previously employed by the former securities firm Kidder, Peabody & Co. |
John Spencer |
Mr. John N. Spencer, Jr., CPA, is Independent Director of MRI Interventions Inc. Mr. Spencer is a certified public accountant and was a partner of Ernst & Young LLP where he spent more than 38 years until his retirement in 2000. At Ernst & Young, he was the partner in charge of its life sciences practice for the southeastern United States. Mr. Spencer serves on the board of directors of GeoVax Labs, Inc., a publicly traded biotechnology company, and until April 2009, served on the board of directors of Firstwave Technologies, Inc., formerly a publicly traded customer relationship management software company. In addition, he serves as a consultant to various companies, primarily relating to financial accounting and reporting matters. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Kimble Jenkins |
623,508 |
David Carlson |
394,298 |
Peter Piferi |
495,908 |
Robert Korn |
-- |
Oscar Thomas |
438,621 |
Carol Barbre |
116,291 |
Philip Pizzo |
-- |
Michael Ryan |
-- |
Paul Bottomley |
-- |
Charles Koob |
-- |
James Malernee |
-- |
Michael Pietrangelo |
-- |
Andrew Rooke |
-- |
John Spencer |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Kimble Jenkins |
0 | 0 |
David Carlson |
0 | 0 |
Peter Piferi |
0 | 0 |
Robert Korn |
0 | 0 |
Oscar Thomas |
0 | 0 |
Carol Barbre |
0 | 0 |
Philip Pizzo |
0 | 0 |
Michael Ryan |
0 | 0 |
Paul Bottomley |
0 | 0 |
Charles Koob |
0 | 0 |
James Malernee |
0 | 0 |
Michael Pietrangelo |
0 | 0 |
Andrew Rooke |
0 | 0 |
John Spencer |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
SPENCER JOHN N JR |
1,500 | $1.32 |
CONWAY BRUCE C |
2,500 | $1.48 |
CONWAY BRUCE C |
2,300 | $1.50 |
CONWAY BRUCE C |
200 | $1.49 |
CONWAY BRUCE C |
2,000 | $1.50 |
CONWAY BRUCE C |
2,500 | $1.58 |
CONWAY BRUCE C |
2,500 | $1.56 |
CONWAY BRUCE C |
2,500 | $1.55 |
CONWAY BRUCE C |
100 | $1.56 |
CONWAY BRUCE C |
3,400 | $1.58 |
CONWAY BRUCE C |
2,500 | $1.53 |
CONWAY BRUCE C |
5,050 | $1.55 |
PIETRANGELO MICHAEL A |
125,000 | $0.00 |
SPENCER JOHN N JR |
10,000 | $1.20 |
CONWAY BRUCE C |
100,000 | $0.00 |
MALERNEE JAMES K JR |
100,000 | $1.20 |
KOOB CHARLES E |
8,594 | $2.40 |
SPENCER JOHN N JR |
8,646 | $2.40 |
BOTTOMLEY PAUL A |
7,917 | $2.40 |
RYAN MICHAEL J |
4,167 | $2.40 |
PIETRANGELO MICHAEL A |
8,906 | $2.40 |
CONWAY BRUCE C |
5,365 | $2.40 |
MALERNEE JAMES K JR |
8,333 | $2.40 |
CONWAY BRUCE C |
1,000 | $2.25 |
CONWAY BRUCE C |
1,000 | $2.00 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
